Bill Text: CT SB00191 | 2014 | General Assembly | Comm Sub

NOTE: There are more recent revisions of this legislation. Read Latest Draft

---

Bill Title: An Act Concerning Health Insurance Coverage Of Orally And Intravenously Administered Medications.

Spectrum:

Status: (Engrossed - Dead) 2014-05-04 - House Calendar Number 513 [SB00191 Detail]

Download: Connecticut-2014-SB00191-Comm_Sub.html

---

General Assembly		Raised Bill No. 191
February Session, 2014		LCO No. 964
		*_____SB00191INS___031414____*
Referred to Committee on INSURANCE AND REAL ESTATE
Introduced by:
(INS)

AN ACT CONCERNING HEALTH INSURANCE COVERAGE OF ORALLY AND INTRAVENOUSLY ADMINISTERED MEDICATIONS.

Be it enacted by the Senate and House of Representatives in General Assembly convened:

Section 1. (NEW) (Effective January 1, 2015) Each insurance company, hospital service corporation, medical service corporation, health care center, fraternal benefit society or other entity that delivers, issues for delivery, renews, amends or continues in this state individual health insurance policies providing coverage of the type specified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 of the general statutes and that provide coverage for intravenously administered medications for the treatment or palliation or therapeutic intervention for the prevention of disabling or life-threatening chronic diseases shall provide coverage for orally administered medications for such treatment, palliation or intervention on a basis no less favorable than intravenously administered medications.

Sec. 2. (NEW) (Effective January 1, 2015) Each insurance company, hospital service corporation, medical service corporation, health care center, fraternal benefit society or other entity that delivers, issues for delivery, renews, amends or continues in this state group health insurance policies providing coverage of the type specified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 of the general statutes and that provide coverage for intravenously administered medications for the treatment or palliation or therapeutic intervention for the prevention of disabling or life-threatening chronic diseases shall provide coverage for orally administered medications for such treatment, palliation or intervention on a basis no less favorable than intravenously administered medications.

This act shall take effect as follows and shall amend the following sections:
Section 1	January 1, 2015	New section
Sec. 2	January 1, 2015	New section

INS

Joint Favorable